Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-07-04
2006-07-04
Maier, Leigh C. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S056000, C514S057000
Reexamination Certificate
active
07071174
ABSTRACT:
This invention encompasses methods for manufacturing purified, high molecular weight sulfated polysaccharide compositions that inhibit pancreatic cholesterol esterase and lower cholesterol in the blood stream.
REFERENCES:
patent: 2755275 (1956-01-01), Cushing
patent: 3175942 (1965-03-01), Anderson
patent: 3507855 (1970-04-01), Whistler
patent: 3511910 (1970-05-01), Halleck
patent: 3624069 (1971-11-01), Schweiger
patent: 3627872 (1971-12-01), Parkinson
patent: 3846541 (1974-11-01), Howard
patent: 3956173 (1976-05-01), Towle
patent: 4223023 (1980-09-01), Furda
patent: 4389523 (1983-06-01), Okajimia et al.
patent: 4480091 (1984-10-01), Brewer
patent: 4623539 (1986-11-01), Tunc
patent: 4642313 (1987-02-01), Matsumoto et al.
patent: 4814437 (1989-03-01), deBelder et al.
patent: 4859703 (1989-08-01), Krause
patent: 5017565 (1991-05-01), Lange et al.
patent: 5063210 (1991-11-01), Lange et al.
patent: 5173408 (1992-12-01), Lange et al.
patent: 5429937 (1995-07-01), Lange et al.
patent: 5432058 (1995-07-01), Lange et al.
patent: 6632801 (2003-10-01), Lange et al.
patent: 953626 (1964-03-01), None
patent: 1164569 (1969-09-01), None
patent: 1433732 (1976-04-01), None
patent: 1053143 (1996-12-01), None
patent: 4943937 (1974-11-01), None
patent: 138202 (1984-08-01), None
patent: 164722 (1989-09-01), None
patent: 0015435 (1990-02-01), None
patent: WO 90/12579 (1990-11-01), None
East, C. et al “Combination Drug Therapy for Familial Combined Hyperlipidemia” Ann. Int. Med., 1988, vol. 109, pp. 25-32.
Goto, et al., “Effect of Dextran Sulfate (MDS) on Prevention of Iscehmic Heart Disease in Double Blind Primary Prevention Trial”,J. Clin. Biochem, 2: 55-70 (1987).
Bosner, et al., “Receptor-like Function of Heparin in the Binding and uptake of neutral lipids”,Proc. Natl. Acad. Sci. 85: 7438-7442 (1988).
Hoffman, et al., “Studies on the Blood-Anticoagulant Activity of Sulphated Polysaccharides with Different Uronic Acid Content”,Carbohydrate Polymers, 2: 115-121 (1982).
Cook, et al., “Comparative Pharmacology and Chemistry of Synthetic Sulfated Polysaccharides”,Arch. Int. Pharmacody., 1-19 (1963).
Lange, III Louis G.
Reardan Dayton T.
Spilburg Curtis A.
CV Therapeutics Inc.
CV Therapeutics, Inc.
Maier Leigh C.
LandOfFree
Method and composition for inhibiting cholesterol esterase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for inhibiting cholesterol esterase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for inhibiting cholesterol esterase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3571026